Bio-thera Solutions
Clinical trials sponsored by Bio-thera Solutions, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New keytruda copycat tested in lung cancer patients after surgery Results expected Feb 2027 (estimated)
- New hope for diabetes-related vision loss: experimental drug faces final test Results expected Apr 2027 (estimated)
- New targeted drug BAT8008 enters human testing for Hard-to-Treat cancers Results expected May 2027 (estimated)
-
Experimental cancer drug BAT8007 tested in early trial – but study halted
Disease control Stopped earlyThis early-phase trial tested a new drug called BAT8007 in 93 people with advanced solid tumors that had stopped responding to standard treatments. The drug is designed to target a protein called Nectin-4 on cancer cells and deliver a chemotherapy agent directly to them. The main…
Phase 1 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New lung cancer drug shows promise in Head-to-Head trial
Disease control Stopped earlyThis study tested a new drug called BAT3306 against the standard treatment Keytruda, both combined with chemotherapy, in 162 people with advanced non-small cell lung cancer. The goal was to see if BAT3306 works as well as Keytruda in shrinking tumors. The trial was stopped early,…
Phase 3 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC